Articles Tagged With: tenofovir
-
Trial Underway for Vaginal Ring Device Designed for HIV Prevention
Researchers are evaluating a vaginal ring designed to protect women against both HIV and herpes simplex virus type 2 in a Phase I study. The trial is being conducted by researchers from the National Institutes of Health-funded Microbicide Trials Network at three U.S. sites in Alabama, California, and Pennsylvania.
-
Injectable Implant Focus of HIV Treatment/ Prevention Research
Researchers with the University of North Carolina at Chapel Hill and the Centers for Disease Control and Prevention are examining a new drug delivery system that uses dolutegravir, an established HIV drug, in a potential longacting treatment and prevention system. The system has been tested in animal models.
-
Research Examines Use of Tenofovir Gel in Women
As HIV infection continues to be a major public health issue, tenofovir gel is being researched as a topical pre-exposure prophylaxis strategy for HIV prevention in women.
-
Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate
The FDA has approved a new prodrug of tenofovir. Tenofovir alafenamide has replaced the tenofovir disoproxil fumarate component of two commonly used drug combinations for HIV-1 infection.